Murphy Pohlad Asset Management LLC Invests $458,000 in Teladoc Health, Inc. (NYSE:TDOC)

Murphy Pohlad Asset Management LLC purchased a new stake in shares of Teladoc Health, Inc. (NYSE:TDOC - Free Report) in the fourth quarter, according to its most recent disclosure with the SEC. The firm purchased 50,400 shares of the health services provider's stock, valued at approximately $458,000.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in TDOC. Bank of Montreal Can lifted its position in shares of Teladoc Health by 470.6% during the 2nd quarter. Bank of Montreal Can now owns 94,466 shares of the health services provider's stock valued at $926,000 after acquiring an additional 77,909 shares during the last quarter. Xponance Inc. acquired a new stake in shares of Teladoc Health during the 2nd quarter valued at $105,000. AQR Capital Management LLC lifted its position in shares of Teladoc Health by 9.1% during the 2nd quarter. AQR Capital Management LLC now owns 675,707 shares of the health services provider's stock valued at $6,608,000 after acquiring an additional 56,202 shares during the last quarter. Millennium Management LLC lifted its position in shares of Teladoc Health by 11.8% during the 2nd quarter. Millennium Management LLC now owns 409,669 shares of the health services provider's stock valued at $4,007,000 after acquiring an additional 43,260 shares during the last quarter. Finally, The Manufacturers Life Insurance Company lifted its position in shares of Teladoc Health by 195.3% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 95,307 shares of the health services provider's stock valued at $932,000 after acquiring an additional 63,028 shares during the last quarter. 76.82% of the stock is owned by institutional investors.

Insider Buying and Selling

In related news, insider Carlos Nueno sold 2,389 shares of the business's stock in a transaction that occurred on Monday, December 2nd. The stock was sold at an average price of $11.93, for a total value of $28,500.77. Following the completion of the sale, the insider now directly owns 2,890 shares in the company, valued at approximately $34,477.70. The trade was a 45.25 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Corporate insiders own 0.95% of the company's stock.

Teladoc Health Stock Performance

TDOC traded down $0.09 on Monday, hitting $10.07. The company had a trading volume of 3,458,227 shares, compared to its average volume of 3,999,467. The company's fifty day moving average price is $10.08 and its 200 day moving average price is $9.07. Teladoc Health, Inc. has a 1-year low of $6.76 and a 1-year high of $21.74. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.73 and a quick ratio of 1.69. The stock has a market cap of $1.73 billion, a price-to-earnings ratio of -1.74 and a beta of 1.01.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently commented on TDOC shares. Royal Bank of Canada increased their price objective on Teladoc Health from $11.00 to $12.00 and gave the company an "outperform" rating in a research report on Friday, January 24th. The Goldman Sachs Group assumed coverage on Teladoc Health in a report on Friday, November 15th. They issued a "buy" rating and a $14.00 target price for the company. Deutsche Bank Aktiengesellschaft increased their target price on Teladoc Health from $10.00 to $12.00 and gave the company a "hold" rating in a report on Friday, November 1st. Oppenheimer reduced their target price on Teladoc Health from $14.00 to $12.00 and set an "outperform" rating for the company in a report on Friday, January 24th. Finally, Evercore ISI increased their target price on Teladoc Health from $8.00 to $9.00 and gave the company an "in-line" rating in a report on Tuesday, October 8th. Fourteen research analysts have rated the stock with a hold rating and seven have given a buy rating to the company's stock. According to MarketBeat.com, the stock presently has a consensus rating of "Hold" and an average target price of $12.08.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.